Progression-free survival in control arms of clinical trials: Analysis of FDA cancer drug approvals between 2014 and 2023. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...

The Inflation Reduction Act represents a landmark shift in U.S. drug pricing regulation, introducing direct federal negotiation of drug prices for the first time. Notably, the IRA imposes earlier ...

Biologics are diverse, organic-based treatments like vaccines and gene therapy, requiring specific conditions for effectiveness. Unlike small molecules, biologics show batch variability and involve ...

Forbes contributors publish independent expert analyses and insights. Ge Bai is professor of accounting & health policy at Johns Hopkins. Biologic drugs, made from living organisms and usually taken ...

Last month, the Centers for Medicare & Medicaid Services began meeting with patients who use the 15 drugs it selected for the second round of Medicare price “negotiations” — including weight-loss ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...

New composition of matter IP filed for chemically distinct, orally active, and highly potent small molecule APJ agonists EMERYVILLE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (BIOA) ...

WASHINGTON - The Food and Drug Administration announced Wednesday that it plans to streamline the approval process for cheaper, "biosimilar" alternatives to biologic drugs in an effort to reduce ...